Skip to main content
. 2017 Dec 5;5(1):231–242. doi: 10.1007/s40744-017-0090-2

Fig. 4.

Fig. 4

Proportions of patients achieving an ACR20/50/70 response and DAS28-CRP < 2.6 at week 12. ACR American College of Rheumatology, DAS28-CRP 28-joint disease activity score by C-reactive protein, DMARD disease-modifying antirheumatic drug, q2w every 2 weeks